330712X

Ceramide LIPIDOMIX^™ 质谱标准品

Avanti Research^™ - A Croda Brand

• 同義詞: LIPIDOMIX^™质谱标准品, 溶液（1:1二氯甲烷：甲醇）
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 形狀: solution (1:1 dichloromethane:methanol)
• 包裝: ampule of 1 × 1 mL (330712X-1EA)
• 製造商／商標名: Avanti Research^™ - A Croda Brand
• 運輸包裝: dry ice
• 儲存溫度: −20°C

描述

包裝

2 mL棕色玻璃密封安瓿

成分

Ceramide LIPIDOMIX质谱标准品是1 mL（1:1）二氯甲烷:甲醇溶液，含有以下成分：

混合物成分目标浓度(μM)

• C16神经酰胺(d18:1/16:0)30
• C18神经酰胺(d18:1/18:0)15
• C24神经酰胺(d18:1/24:0)75
• C24:1神经酰胺(d18:1/24:1(15Z))37.5

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

LIPIDOMIX is a trademark of Avanti Polar Lipids, LLC

套裝中的組件也可單獨購買

• 860516P C16 Ceramide (d18:1/16:0), Avanti Research^™ - A Croda Brand 16.1μg/mL
• 860518P C18 Ceramide (d18:1/18:0), Avanti Research^™ - A Croda Brand 8.5μg/mL
• 860524P C24 Ceramide (d18:1/24:0), Avanti Research^™ - A Croda Brand 48.8μg/mL
• 860525P C24:1 Ceramide (d18:1/24:1(15Z)), Avanti Research^™ - A Croda Brand 24.3μg/mL

安全資訊

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H315,H319,H336,H351,H370
• 防範說明: P210 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311 - P305 + P351 + P338
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 2 - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 1 - STOT SE 3
• 標靶器官: Central nervous system, Eyes,Central nervous system
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 49.5 °F
• 閃點（°C）: 9.7 °C